Oncology CRO Email us info@sms-oncology.com
Follow us on

The 4D oncology CRO

Drug – Data – Dossier

The path to successful development of oncology drugs is geared by generation of clinical data that builds up a compliant regulatory dossier. Oncology drug development is complex and direction is required to navigate a safe passageway by avoiding risks and leveraging opportunities to increase the chances of success.


SMS-oncology adds an extra dimension to clinical cancer research by providing direction to our sponsors. During the study we turn complex data into meaningful insights using our oncology expertise. This information helps our sponsors to make informed decisions, stay in control, mitigate risks, identify opportunities and collect the right data to build the regulatory dossier. SMS-oncology: an oncology CRO adding value by providing direction.

Our oncology services

Clinical operations Read more

Clinical operations

From initiation and implementation to completion of oncology clinical trials with a specialization in:
• Early phase oncology trials
• Immuno-oncology trials

Consultancy Read more


From strategic expert advice on oncology drug development and trial design to protocol writing and scientific advisory boards.

Integrated services Read more

Integrated services

From upfront strategic advice translated into clinical operations to frequent meaningful insights during study conduct.

Our advantages

Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise


23-24 November 2015

Our Director Business Development Mohamed Khater is attending the European Business Development Conference in Antwerp today and tomorrow. He is looking forward to meeting you! 

23 November 2015

Today, Lindy Bosch (Business Developer at SMS-oncology) is attending the Dutch Life Sciences conference. She is looking forward to meeting you at the Agora Theater in Lelystad!

20-21 November 2015

Is immuno-oncology the new era of cancer medicine? Our colleagues Nadina Grosios (Director Consultancy) and Lindy Bosch (Business Developer) hope to find out during the ESMO Symposium on Immuno-Oncology, in Lausanne, Switzerland the coming two days (20-21 November). Looking forward to seeing you there!

Conference schedule

1-2 December 2015

Clinical Operations in Oncology Trials, Amsterdam, The Netherlands

18 February 2016

Innovation for Health, Rotterdam, The Netherlands

4-6 April 2016

BIO-Europe Spring, Stockholm, Sweden

Recent blog posts

26 October 2015

SMS-oncology: Q, Q, Q!